Prognostic impact of bulky lymphademopathy. Progression-free (A) and overall survival (B) for patients with versus without bulky lymphadenopathy detected by pretherapeutic imaging methods (CT scan or ultrasound). No significant difference in progression free (P = .2) and overall survival (P = .08) was assessed.